Transcend Capital Advisors’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$336K	Sell	9,339 -2	-0%	-$72	0.03%	425
2025 Q1	$368K	Buy	9,341 +2	+0%	+$79	0.03%	426
2024 Q4	$281K	Buy	9,339 +22	+0.2%	+$662	0.02%	456
2024 Q3	$218K	Buy	+9,317	New	+$218K	0.01%	556